Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BeyondSpring Inc. (BYSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
13.32-0.63 (-4.52%)
At close: 4:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.95
Open14.03
Bid13.05 x 900
Ask13.45 x 1800
Day's Range12.98 - 14.03
52 Week Range8.90 - 33.00
Volume938,144
Avg. Volume971,357
Market Cap520.899M
Beta (5Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)-1.89
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est60.67
  • GlobeNewswire

    BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference

    NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced that management will participate in a Fireside Chat and host one-on-one investor meetings during the 4th Annual Evercore ISI HealthCONx Conference, taking place November 30-December 2, 2021. Details for the Fireside Chat can be found below: 4th Annual Evercore ISI HealthCONx ConferenceDate:Tue

  • GlobeNewswire

    BeyondSpring Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference

    NEW YORK, Nov. 12, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced that management will present at and host one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021. The presentation will be available on-demand for attendees during the virtual conference beginning on November 18,

  • GlobeNewswire

    BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors

    NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a clinical stage biopharmaceutical company focused on the development of innovative cancer therapeutics, today announced the appointment of Mark Santos, RPh, to its Board of Directors, effective immediately. Mr. Santos has over 30 years of executive experience across the healthcare and pharmaceutical industries, currently serving as the Senior Vice President of Pharma Strate

Advertisement
Advertisement